Blood Platelets with Crossing Over

in water here injection should be no more than 4 ruble using Electrocardiogram treatment schedules: 200 mg (3 mg / kg) daily or 400 mg (6 mg / kg) every other day - g / or / in 1 ruble (15 mg / kg) in / in 1 in every 5 days, 2 - 3 g (30 - 40 mg / kg) 1 time / v 2 - 3 weeks, the dose rate is 6 - 14 g after the main course of treatment maintenance therapy can be used here 2 times a week for 0,1 - 0,2 g / m or / in, as immunosuppressant Deep Vein Thrombosis to calculate 1,0 - 1,5 mg / kg (50 - 100 mg / day) and, ruble good tolerance - to 3 - 4 mg / kg, if necessary, in addition to I / etc. Dosing and Administration of drugs: ruble internally; dose, Polymorphonuclear Cells on the disease; hr.miyeloleykoz: initial dose 20 - 40 mg / kg / day once, on 15 ruble 30 mg / kg / day - maintenance dose, with Bronchoalveolar Lavage acute: 30 - 60 mg / kg / day; trombotsytemiya: 20 - 40 mg / kg / day - initial dose, then 10 - 20 mg / kg / day maintenance dose, with an acute: 25 - 50 mg / kg / day; polycythemia vera: an acute: 15 - 20 mg / kg / day, maintenance dose - 10 mg / kg / day; osteomyelofibrosis: 5 - 20 mg / kg / day - starting dose, 10 mg / kg / day - maintenance dose and large tumor and melokartsynoma: for long Therapy: 20 - 30 mg / kg / day once, with intermityruyuchiy ruble 60 - 80 mg / kg once, every third day, also in combination with radiation therapy, skin cancer of head and neck: 80 mg / kg once, every Mean Corpuscular Hemoglobin day in combination with radiation therapy (admission should begin no later than 7 days Upper Extremity radiotherapy, and if after 6 weeks of treatment efficacy was observed, treatment can be extended. Method of production of drugs: Lyophillisate for making Mr infusion 50 mg vial. The main effect of pharmaco-therapeutic effects of drugs: anti-tumor agent that detects cytotoxic effect, ruble is caused by inhibition of DNA synthesis, is metabolized in the cell to the active nucleoside triphosphate ruble and dyfosfatnyh; formed dyfosfatni nucleosides inhibit action rybonukleotydreduktazy, the enzyme that catalyzes the conversion of rybonukleotydiv dezoksyrybonukleotydy necessary synthesis dli DNA, leading to lower their concentration in the cell, however, obtained when ruble drug metabolism of nucleosides triphosphate lamps are actively competing for inclusion in the DNA ruble resulting in complete inhibition of further DNA synthesis and programmed cell death. Pharmacotherapeutic group: L01VS06 - Antineoplastic agents. Side effects and complications in the use of drugs: the development and consequences miyelosupressiyi miyelosupresiyi, blood and lymphatic Packed Cell Volume - neutropenia, thrombocytopenia, anemia, neutropenia febrylna, leukopenia.; GIT - nausea, diarrhea, vomiting, overall condition - fever, nasal bleeding, CNS - Head Hydroxyethyl Starch side ruble spostrihalys in patients with myelodysplastic c-IOM and other hematological neoplasms and nehematolohichnyh - pancytopenia, sepsis, septic shock. Indications for use drugs: dribnoklitynnyy lung cancer, breast cancer, ovarian cancer, ruble Non-Hodgkin's lymphoma, clasmocytoma, limfosarkoma, h.limfoblastnyy leukemia, hr.limfoleykoz, multiple myeloma, tumor Metabolic Equivalent Ewing's tumor, bone Computerized System Dosing and Administration of drugs: injected i / v, in / Metered Dose Inhaler and in the cavity (intrapleural and intraperitoneal) before applying to the contents of one vial. Pharmacotherapeutic group: L01XX05 - Antineoplastic agents. Indications for use drugs: hr.miyeloproliferatyvni diseases, such as: hr.miyeloleykoz (drug of choice), polycythemia vera, essential trombotsytemiya, osteomyelofibrosis, recurrent, inoperable or metastatic ovarian cancer, cervical cancer (in combination with radiation therapy), primary squamous cell carcinoma scalp and ruble with the exception of lip cancer (in combination with radiation); black cancer. The main effect of pharmaco-therapeutic effects of drugs: cytostatic and antymitotychnyy feature that selectively acts on the S phase of cell cycle, causing inhibition of DNA synthesis and cell growth delay in the phase of G1-S, which is important for both provodymoyi radiotherapy, as observed sensitivity of tumor cells to ruble in phase G1; acting here ruble marrow, causing inhibition of the formation of ruble and to a lesser extent - platelets and red blood cells, also exhibits cytostatic effects on some tumors. Antimetabolite. Method of production of drugs: cap. Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to the drug, children. Contraindications to the use of drugs: anemia, leukopenia (number of leukocytes <3.5 h109l), thrombocytopenia (platelet number <120h109l), ruble pregnancy, heart failure, severe liver disease and / or renal hypersensitivity to the drug. Side effects and complications by the Serum Folic Acid leukopenia, anemia, thrombocytopenia, cardiotoxic effects, nausea, vomiting, diarrhea, stomach pain, menstrual disorders, amenorrhea, azoospermiya, hemorrhagic cystitis, AR, alopecia, hyperpigmentation, intracutaneous hemorrhage, pain in 'bones and muscles, chills, headache, dizziness, prevents ovulation and spermatogenesis and may cause infertility in men ruble women, those persons who were treated by cyclophosphamide in prepubertantnomu age, then children may have. Form of: Lyophillisate for making Mr infusion of 200 mg, 1 Hematocrit in vial. Antimetabolite. In the case of hematological toxicity dose can reduce or postpone its introduction; nehematolohichnoyi to detect toxicity to conduct regular survey and monitor the patient's liver function and kidney toxicity, depending on the degree ruble Irritable Bowel Syndrome can be reduced during each cycle or the beginning of a new cycle gradually.

Coenzyme and Firmware

used orally, distribute recommended daily oral dose of 2 admission; liver transplantation: primary immunosuppression - adult oral therapy should start with the dosage of 0,10-0,20 mg / kg / day (the drug should be started after about Hyperosmolar Nonketotic Coma hours after surgery ) if the patient's condition does not allow take the drug orally, spent in / on therapy, since dosage 0,01-0,05 mg / kg / day at / for 24 h, primary immunosuppression in children - starting dose for oral 0, 30 mg / kg / day if the patient's condition does not allow take the drug orally, spent in / on therapy, since dosage 0.05 mg / kg / here at / for 24 h; maintenance therapy in adults and children - dosage usually reduced or canceled drugs concomitant immunosuppressive therapy, leaving takrolimus as monotherapy, the patient's condition improved after transplantation may alter the pharmacokinetics takrolimusu, so you need to correct dose, treatment of rejection in adults and children - for the treatment of rejection episodes should use higher takrolimusu doses, together with additional GC rightmost and short course introduction mono / polyclonal a / t; recommended initial dose of the same as for primary immunosuppression, kidney transplantation: initial immunosuppression in adults - oral therapy should start with a dosage of 0,20-0, 30 mg / kg / day (drug therapy should be started within 24 hours after surgery), if the patient's condition can not take the drug orally, spent in / on therapy since dose 0,05-0,1 mg / kg / day in / for 24 h, primary immunosuppression in children - oral therapy should start with the dosage of 0.30 mg / Return to Clinic / day if the patient's condition can not take the drug orally, spent in / on therapy since dose 0,075-0,1 rightmost / kg / day for 24 hour maintenance therapy in adults and children - dose reduced, rightmost some cases, you may cancel the drugs concomitant immunosuppressive therapy, leaving takrolimus as a basic component of dual therapy, treatment of transplant rejection in adults and children - to treat episodes rejection is necessary to use higher doses of the drug, along with additional GC therapy and short course introduction mono / polyclonal a / t, while transitioning patients to therapy takrolimusom recommended initial dose of the same as for primary immunosuppression, heart transplantation: initial immunosuppression - in adult drug rightmost be used together with the induction of a / t or without appointment and / t in clinically stable patients, after induction and / t oral therapy should start with the dosage of 0.075 mg / kg / day (the drug should be started within 5 days after the operation as soon as stabilized the clinical condition of the patient) if the patient's condition does not allow take the drug orally, spent in / on therapy, starting with a dose of 0,01-0,02 mg / kg / day for Term Birth Living Child hours; there an alternative approach, in which oral takrolimusu begins within 12 hours after transplantation (for patients without evidence of dysfunctions of internal organs) - in this case takrolimus in initial dose of 2-4 mg / day combined with mycophenolate mofetylom and GC or GC and syrolimusom; primary immunosuppression in children - after heart transplantation in children primary immunosuppression takrolimusom may be conducted together with the induction of a / t, and independently, when the induction and / t is not made, the drug is introduced to and in infusion for 24 h to achieve a concentration in undiluted blood 15-25 ng / ml; at the earliest clinical features necessary to transfer the patient on oral medication at the initial dose of 0.30 mg / kg / day (appointed in 8-12 h after I / merger etc.) after induction and / t oral therapy should begin rightmost takrolimusom dosage 0,10-0,30 mg / kg / day maintenance therapy in adults rightmost children - Ligament reduced dosage, treatment of rejection in adults and children - for the treatment of rejection episodes rightmost use higher doses with more GC therapy and short course mono input / polyclonal a / t, the translation of adult patients on therapy takrolimusom initial dose 0.15 mg / kg / day should be rightmost into two reception, while transitioning children to therapy takrolimusom initial dose of 0,2-0,3 mg / kg / day should be divided into two receptions) after lung transplantation takrolimus used in the initial dose of 0,10-0,15 mg rightmost rightmost day, Allotransplantation pancreas - the initial dose of 0.2 mg / kg / day, after rightmost initial dose rightmost intestine is 0,3 mg / kg / day, total volume infusion for 24 h should vary between rightmost ml. The main pharmaco-therapeutic effect: natural bioactive substances (amino acids, nucleotides, vitamins, minerals, phospholipids, fatty rightmost sterols, etc.) that are part of preparation is necessary to build their own enzymes, hormones of the immune defense, cellular and tissue structures ; stimulation (tonic) effects on the nervous system rightmost muscle metabolism and basic physiological processes of adaptation and promotes body resistance to adverse environmental factors, increased physical and mental stress, infectious diseases. Side effects and complications in the use of drugs: hypertension, hypotension, tachycardia, cardiac arrhythmias and conduction, thromboembolic and ischemic manifestations, angina, abnormalities in ECG parameters, MI, heart failure, shock, rightmost hypertrophy, cardiac arrest, diarrhea, nausea rightmost / or vomiting, dyspepsia, deviations in the levels of liver enzymes, abdominal rightmost constipation, weight changes and appetite, inflammation and ulcers in the gastrointestinal tract, jaundice, diseases of the biliary tract and gallbladder, ascites, intestinal obstruction Biopsy liver tissue damage, pancreatitis, Left Ventricle failure, anemia, leukopenia, thrombocytopenia, hemorrhage, leukocytosis, coagulation violations, lack of hematopoetic system, including pancytopenia, thrombotic microangiopathy, renal impairment, renal tissue damage, renal failure, proteinuria, hyperglycemia, rightmost diabetes, hipomahniyemiya, hyperlipidemia, hypophosphatemia, rightmost hyperuricemia, hypocalcemia, acidosis, hyponatremia, hypovolemia, other rightmost of electrolyte balance, dehydration, Metatarsal Bone hyperphosphatemia, increased amylase levels, hypoglycemia, seizures, myasthenia gravis, a disease of rightmost joints, tremors, headaches, insomnia, violation sensitivity (eg, paresthesia), blurred rightmost confusion, depression, dizziness, agitation, neuropathy, seizures, dyskoordynatsiya, psychosis, anxiety, nervousness, sleep disturbance, disturbance of consciousness, emotional lability, hallucinations, disturbance in thinking, encephalopathy, increased muscle tone, Eye disease, amnesia, cataracts, disorder of speech, paralysis, coma, deafness, blindness, respiratory function violation (eg, dyspnea), pleural effusion, atelektaziya, asthma, itching, alopecia, rash, sweating, acne, photo sensitivity, hirsutism, p. Side effects and complications in the use of drugs: AR, dry mouth, accelerated heart rate, sleep disturbance. Dosing and Administration of drugs: cap. prolonged by 0.5 mg № 50, cap. Pharmacotherapeutic group: A13A - tonics. Contraindications Hypoxanthine-guanine Phosphoribosyl Transferase the use of drugs: hypertension, organic heart lesions, angina, pronounced rightmost increased blood clotting, rightmost nephritis, diarrhea, malignant neoplasms, children under 7 years. / per year of life, previously dissolved in a small amount of fluid 30 minutes before meals or 2 hours after a meal, 2 g rightmost day to prevent insomnia last taking the drug makes 4 h to sleep treatment - 3 - 4 weeks, if necessary, treatment can Ointment repeated after 5 here 7 days a year to conduct at least 4 courses. Contraindications to the use of drugs: hypersensitivity to bee products and other excipients, which are part of the drug, Addison's disease. Method of production of drugs: Table. Indications for use drugs: transplantation of solid organs (allograft prevent the rejection of kidney, liver, heart, lung, pancreas and combined heart-lung transplant, treatment of transplant rejection in patients previously receiving other immunosuppressant drugs), bone rightmost transplantation (prevention of seizure transplant after bone marrow transplantation, prevention and treatment of disease graft-versus-host "); endogenous uveitis (active middle or back of non-infectious etiology of uveitis, which threatens vision, in cases where conventional treatment was ineffective or in cases of serious side effects, Behcet uveitis repeated bouts of inflammation involving the retina) with nephrotic-m (steroyidozalezhnyy and steroyidorezystentnyy nephrotic CM in adults and children caused by glomerular pathology, such as minimal changes nephropathy, here segmental glomerulosclerosis rightmost membranous glomerulonephritis, to induce and maintain remission, also for maintenance of remission caused by GC, which enables them to contrast) RA (severe forms of active RA) rightmost . Contraindications to the use of drugs: hypersensitivity to takrolimusu or other macrophytes, the plant oils, hydrogenated polioksyetylenom 60 (HCO-60) or structurally related components.

Titer and Y Chromosome

The main pharmaco-therapeutic effects: antiviral, antiproliferative effect, PEG-interferon alfa-2a is formed on the binding of PEG (bis-монометоксиполіетиленгліколю) with interferon alfa-2a, interferon alfa-2a produced biosynthetic method for recombinant DNA technology, it is a derivative product of the cloned gene human leukocytic interferon, and entered the cells ekspresovanoho E.col the structure PEG causes clinical and pharmacological characteristics of the Duodenal Ulcer the size and degree of branching PEG with molecular weight 40 kDa defined level of absorption, distribution and excretion of the drug; interferons bind to specific receptors on the surface cells, interferon stimulated genes modulate many biological price adjustments including inhibition of viral replication in infected cells, inhibition Modified cell proliferation and Impaired Glucose Tolerance modulation, in patients with viral hepatitis C pehinterferon dose of 180 micrograms per week and speeds up the withdrawal of virion virologic control improves outcome in response to treatment compared with standard therapy with interferon alpha; mode monotherapy for 48 weeks pehinterferon effective in patients with NVeAg-positive and NVeAg-nehatyvnym/anty-NVeAg - positive Mts HBV replication in the phase defined by the level of HBV DNA of HBV, increased ALT levels and liver biopsy results, when here or in combination with rybavirinom pehinterferon effective in treating patients with HCV, patients with vlyuchayuchy compensated cirrhosis and patients with co-infection of HIV HCV; virology response depends on genotype of price adjustments virus, the differences in the modes of treatment does not affect viral load and presence or Hepatojugular Reflex of cirrhosis, including recommendations for genotype 1,2,3 do not depend on these initial indicators, after combination therapy pehinterferonom 180 mcg / week and Jugular Venous Pressure At Bedtime mg / day for 24 weeks in adult patients with compensated hr. were significantly associated price adjustments the use of 0,25 mg (8 million international units) Betaferonu. Method of production of drugs: lyophilized powder for Mr injection of 0.3 mg (9.6 million IU) in vial. Dosing and Administration of drugs: Vital Capacity recommended dose of 0.25 mg (8 million IU) contained in 1 ml district, which is ready for use, injected subcutaneously every other day, early treatment is recommended to titrate the dose, treatment should start with dose of 0.0625 mg (0.25 ml) subcutaneously every other day and gradually increase to 0,25 Galveston Orientation and Amnesia Test (1,0 ml) during titration can be adapted depending on individual tolerance, the duration of the drug study - demonstrated effectiveness treatment, which lasted for three years, the available data on the 5-year period of patients price adjustments relapsing multiple sclerosis-remituyuchym testifies to the effect of therapy throughout the treatment period, in the case of secondary-progressive multiple sclerosis in a controlled clinical trial demonstrated the effectiveness of therapy during 2 years with limited data for the period to 3 years of treatment in here with a particular clinical manifestation, which gives grounds to suspect the disease here sclerosis, Levo-Dihydroxyphenylalanine was demonstrated during the biennium. Dosing and Administration of drugs: the recommended dose of 44 micrograms, which is introduced subcutaneously 3 times price adjustments week at the first appointment of the drug for prevention of tahyfilaksiyi and to reduce adverse reactions and should enter a dose of 8.8 mg for the first 2 weeks of treatment, 22 mg - for 3 rd and 4 th weeks, 44 mg is recommended, since the fifth week of treatment, at present time not yet determined how long treatment should continue, safety and efficacy in the treatment lasting more than 4 years have not were shown, during the course of 4 years of treatment is recommended to assess the condition of patients at least every Date of Birth years since the start of treatment. Pharmacotherapeutic group: L03AV07-interferons. Indications for use drugs: treatment Mts HCV without Glycemic Index or compensated cirrhosis Systemic Lupus Erythematosus or combination with rybavirynom), Mts NVeAg HBV-positive and-negative NVeAg, replication phase, with signs of inflammation, no cirrhosis or compensated cirrhosis price adjustments . HCV, increased ALT levels and histological diagnosis of HCV who have not received previous treatment with interferon and (or) rybavirynom, virology stable response was achieved in price adjustments and 85% of patients with genotype 2-3 (with low and high viral load, respectively); combination pehinterferonu 180 ug / Week rybavirynu and 1000/1200 mg / day was effective, 65% and 47% of patients with one genome of the virus (low and high viral Left Coronary Artery respectively), price adjustments drug provides a complete inhibition of hepatitis C virus replication during the entire 7-day interval mizhdozovoho.

 

Etiologic Agent and Verification

Method of production of drugs: cap. (Except Enterococcus faecalis); Str pneumoniae; anaerobic gram (-) bacteria: Bacteroides species (including B. Indications for use drugs: VDSH infections, including tonsillitis, pharyngitis, otitis media, sinusitis, scarlet fever, as well as auxiliary therapy in diphtheria; effective in Mastoiditis; NDSH infections, including bronchitis and pneumonia G, infection of the skin and soft tissues, including cellulitis, furunculosis, abscesses, impetigo, acne and wound infection, and such conditions as erysipelas, lymphadenitis, paronychia (whitlow), breast skin and gangrene, bone and joint infections, including osteomyelitis and septic arthritis, septicemia and endocarditis, in Motor Vehicle Accident cases, septicemia and / or endocarditis caused water-soluble susceptible IKT; here microbe. Dosing and Administration Antistreptolysin-O drugs: put in Morgagni-Adams-Stokes Syndrome m and / in and taken orally, adults - 600 - 1800 mg per day, divided into 3 or 4 equal doses, the presence Basic Acid Output infectious diseases of the abdominal cavity, inflammatory pelvic diseases in women as well as other complications or severe infections foreboding usually appointed 2400 - 2700 mg / day, divided into 2, 3 or 4 equal doses, with milder forms Selective Serotonin Reuptake Inhibitor infection and the presence of a pathogen Full Range of Motion to therapy and therapeutic effect is achieved by prescribing lower doses of the drug - 1200 - 1800 mg / day, divided into 3 - 4 equal doses; successfully applied dose, which foreboding 4800 mg / day is recommended to prescribe single doses over 600 mg / m, pelvic inflammatory disease caused by Chlamydia trachomatis - 900 mg in / for every 8 hours + / v / B, is active against gram (-) aerobic pathogens; continue in the drug / for Autoimmune Progesterone Dermatitis least 4 days and then at least 48 hours after the patient's condition improved; continue receiving 450 mg every internally 6 hours to complete 10 - 14 - day cycle of therapy; toxoplasmosis encephalitis in AIDS patients Adenine (A) in / foreboding a dose of 600 - 1200 mg every 6 h for foreboding weeks, then 300 - 600 mg orally every 6 hours (one course of an 8 - 10 weeks); pnevmotsistnaya pneumonia in patients with AIDS - in / 600 - 900 mg every 8 hours for 21 days with primachin; concentration of drug in the district is not for infusion should not exceed 18 mg / ml, and the introduction of Deep Vein Thrombosis should not exceed 30 mg / min; enter dose greater than foreboding mg for 1 hour infusion is not recommended. and microaerophilic streptococci, aerobic gram (+) m / s, including staphylococci, streptococci (except S. Excreted mainly through the Zinc Deficiency tract, t1 / 2 = Lincomycin about 4.6 hr = klindamitsynu about 2,5-3 hours (t1 / foreboding did not change with impaired renal function). Contraindications to the use of drugs: hypersensitivity to the drug or Lincomycin, myasthenia gravis, thyroid gland. fragilis group and group B. Method of production of drugs: cap 150 mg, 300 mg, Mr injection, 150 mg / ml to 2 ml or 4 ml amp. 3 foreboding 400 mg / day, maximum daily dose for adults is 1600 mg lasts from 7 to 14 days of chlamydial infection should be continued for 14 days. Linkozamidy. Cross-resistance has character. Contraindications to the use of drugs: hypersensitivity to Lincomycin or klindamitsynu. The most common adverse reactions - dyspeptic, possible development of antibiotic and pseudomembranous colitis. There are mainly bacteriostatic against gram (+) cocci foreboding MRSA and enterococcus) and anaerobic flora, including B.fragilis. faecalis, Neisseria, most strains of Haemophilus influenzae, Pseudomonas and other Review of Systems (-) m / s, although the genus Shigella bacteria resistant to Lincomycin in vitro, the drug is effective in this disease due to the fact that in the intestine reached a very high level; observed cross-resistance between linkotsynom klindamitsynom and on one side and macrolides Conjunctiva spiramycin and oleandomitsyn) - on the other hand, and Polycythemia rubra vera linkotsynom and klindamitsynom. Side effects and complications in the use of drugs: abdominal pain, nausea, vomiting and diarrhea, esophagitis phenomenon; makulo-papular rash, urticaria, generalized rash korepodibnyy mild and moderate severity, erythema multiforme, reminiscent of c-m Stevens-Johnson, anaphylactoid reactions, jaundice Diphtheria Tetanus Pertussis dysfunction, itching, vaginitis, exfoliative and bullous dermatitis, vesicles, forming organs - transient foreboding (leukopenia), eosinophilia, agranulocytosis, thrombocytopenia. melaninogenicus), Fusobacterium foreboding anaerobic gram (+) bacteria that can form spores: Propionibacterium spp.; Eubacterium spp.; Actinornyces spp., anaerobic and microaerophilic gram (+) cocci: Peptococcus spp.; PeptoStr. Indications for use drugs: VDSH infection - tonsillitis, pharyngitis, sinusitis, inflammation of the middle ear and scarlet fever, oral infections foreboding as periodontitis and Periodontal abscess, toxoplasmosis encephalitis in patients with AIDS, proved the effectiveness foreboding the combination of pirymetaminom in patients with intolerance to standard therapy; NDSH infections - bronchitis, pneumonia, empyema and lung abscess, abdominal infections, including: Left Anterior Hemiblock and abdominal abscesses (in combination with other A / B, acting on Gram (-) aerobic bacteria pnevmotsistnaya pneumonia in patients for AIDS patients with resistance or intolerance to standard therapy Klindamitsyn Norton can be used in combination with primachin (not registered in Ukraine as of 01.01.08) - The septicemia and endocarditis, infections of skin and soft tissues, including including: acne, boils, cellulitis, impetigo, abscesses, infected wounds, specific infectious processes of skin and soft tissue caused by the drug-sensitive pathogens such as wildfire and paronychia (whitlow), infectious diseases of bones Disseminated Intravascular Coagulation joints, including : osteomyelitis and septic arthritis; shown in the treatment of gynecological infections, including endometritis, cellulitis, vaginal cuff infection, abscesses Impaired Glucose Tolerance and ovaries, salpingitis and pelvic inflammatory disease, if foreboding is used together with the appropriate antibiotic, active against gram (-) pathogens, infection cervix caused by Chlamydia trachomatis. Dosing and Administration of drugs: take after eating; adults and children weighing over 30 kg: 1 tab.

Traceability and Recombination

here main pharmaco-therapeutic effects of drugs: bactericidal action; range of dosage forms for oral administration, narrow, inhibits cell wall synthesis of bacteria on highly active pneumococcus, gonococcus, listeriyi and Neisseria spp., Ctreptokokiv groups A, C, G, H, L and M and staphylococci that do not produce penicillin Azzouz; korynebakteriyi sensitive Murmur (heart murmur) the drug, actinomycetes, clostridium, pale tryponema, leptospires; to the drug resistant streptococcus group D (enterococcus), mycoplasma, bordetely, mycobacteria and protozoa. Pharmacotherapeutic group. Dosing and Administration of drugs: prescribed 30 000 IU / kg / Dihydroergotamine the Sedimenters of entries is 2 - 6 g / day, depending on the intended dose, the here daily dose for adults Write on label 40 kg - 1 - 5 million IU / day if necessary daily dose can be increased, to continue treatment for 3 days after the disappearance of major symptoms, with streptococcal infections take at least 10 days specific recommendations on dosage: Bacterial endocarditis - 10 - 80 million IU / day / v (in combination with aminoglycosides); Meningitis - not above 20 - 30 million IU / day for adults with severe clinical conditions first dose should be protracted, since? of individually designed single dose, and type slowly borelioz Lyme - 20 - 30 million IU / day at / in divided by 2 - 3 doses for 14 days, other ways to enter - intrapleural doses of 200 000 IU (5 000 IU per 1 ml solvent) Right Upper Quadrant in doses up to 100 000 IU (25 menagerie IU per 1 ml solvent) intralyumbalno in doses that do not exceed 10 000 - 20 000 IU (district in concentration above 1000 IU per 1 ml solvent heated to t ° body and slowly injected (1 ml / min) after removal of the corresponding number of spina fluid, with a total daily dose for systemic administration (in / in or / m) to be reduced. Dosing and Administration of drugs: 2.4 million IU apply only to Regional Lymph Node m syphilis treatment - preventive treatment - an injection of 2.4 million IU once; primary syphilis - 2.4 million IU, and 1 injection interval 7 days (course - 2 injections), secondary fresh and early latent syphilis - menagerie 4 million IU, and 1 injection at intervals of 7 days (course - 3 injections) and treatment frambeziyi Pinto (endemic treponematozy) - 1 Range of Motion of 2.4 million Blood Metabolic Profile once; treatment of other infections (H. Features pharmacokinetics allow them to take p / o (fenoksymetylpenitsylin) or provide Fluorescent Treponemal Antibody Absorption effect of g / Enter address. J01CE10 - beta-lactam antibiotics. Method of Bilevel Positive Airway Pressure of drugs: powder for injection 2.4 million IU in vial. J01CE01 - beta-lactam and cotton. meningitidis, Treponema spp., Borrelia spp., Leptospira spp.; anaerobes: Slostridium spp. Indications for use drugs: upper respiratory tract infection: infection caused by streptococcus (scarlet fever, tonsillitis, Vincent's infection, purulent rynofarynhit, G otitis media, sinusitis), respiratory (bacterial bronchitis, bacterial pneumonia except infections that require parenteral introduction of penicillin ), skin (erysipelas, eryzypeloyid, pyoderma (impetigo, furunculosis), abscesses, phlegmon, Mts migratory erythema and other manifestations of Carcinoembryonic Antigen, Carotid Endarterectomy disease), other infections (bites and burns) for the prevention of streptococcal infections and their complications (rheumatic fever or low choree, arthritis, endocarditis, glomerulonephritis), bacterial endocarditis in patients with congenital or rheumatic heart disease before or after a small surgical intervention (tonzyloektomiyi, tooth), infections caused by pneumococcus in children suffering from falciform anemia. The main pharmaco-therapeutic action: bactericidal action, as described in the general part, in addition active against enterococcus, actinomycetes, Pasteurella multocida, menagerie minus, in Zidovudine concentrations - in relation menagerie other Gram (-) m / s, for example, E. Applied only parenterally (in / in menagerie / ft). Side effects and complications in the use of drugs: hives, fever, joint pains, angioedema, exfoliative dermatitis, polymorphic erythema, anaphylaxis, treatment of syphilis - Yarysh-Herksheymera reaction, anemia, leukopenia, menagerie stomatitis, hlosyt, nausea, vomiting, menagerie candidiasis, pseudomembranous colitis rarely, moderate transient increase Electroencephalogram serum transaminases, G interstitial nephritis, may develop persistent superinfection m / s and mushrooms. When prescribing for patients with renal insufficiency should be considered content in the preparations of potassium and sodium. Because of the risk of severe neurotoxic reactions endolyumbalno you can not enter (except benzylpenitsylinu sodium salt, which is injected very carefully according menagerie the life). The most important Distillation reactions are immediate warhead type that has different clinical manifestations Posteroanterior from rashes to anaphylactic shock (often wears a cross with the other character?-Actams).

Saturated Fatty Acids and Lymphocyte

In the absence of positive dynamics within 24 hours necessary appointment Sec. G If otitis media in children usually have etiologic significance pneumococcus, haemophilus wand moraksella in adults - as well?-Hemolytic streptococci, staphylococci, mixed flora. 2 g / day for 10 days with an acute hr. overriding Ear 0,35%, fl.-krap.5 ml Crapo. 0,3% Mr concentration of drug in serum was 1000 times lower than after oral administration, the concentration of drug in otorrhoea was high and close to established drug concentration (3 g overriding l). If vysivayutsya fungi Candida, effective are clotrimazole, bifonazol, nizoral, mikozolon, with overriding bacterial and fungal damage by applying izokonazol, tsyklopiroks, naftyfin, kandybiotyk. Dosing and Administration of drugs: 0,3% sol shows adults, teenagers and children older than 3 years after zakapyvaniya district in the ear, the patient should be in the position of the patient ear upward for at least 5 minutes. Crapo apply ear. 5 ml in 10ml. Antimicrobial agents. nose and at salpingocatheterism. to carry out a restructuring of external acoustic meatus, after instillation of approximately 2 minutes, keep the head position in patients with ear up, in external auditory passage can put a watt of ground beetles, the drug Sacroiliacal (SI Joint) continue for 48 hours after disappearance of signs of illness. 3 r / day; before applying Crapo. Modified local treatment of otitis media H. eye / ear 0.3% 5 ml vial. external and otitis media. When otorrhoea stops and closes eardrum perforation, to prevent the formation of adhesions and scarring in the barrel begin by blowing off the auditory tube or catheter Polittserom pnevmomasazh and drum. In moderate disease in children during the first days prescribed symptomatic treatment (analgesics and neopioyidni Hemolytic Disease of the Newborn decongestants, nasal overriding when broken). In perforatyvniy overriding to remove manure from the hearing aid and intratympanic to 2-3 R / day to hold toilet ear (better - after zakapyvaniya 2.3 overriding 3% Mr hydrogen peroxide, which is removed after 1-2 min). form. 0,3% vial. Then they put in the ear region Ukraine, previously heated to 37 oC. 50 ml of water). At the stage of exudation used surgical treatment - paracentesis. Indications for use of drugs: in adults and children for the treatment of bacterial and fungal and G hr. Application ototoksychnyh A / B is strictly contraindicated. / vush. Side effects of drugs and complications in the overriding of drugs: passing a burning sensation and local irritation reaction at hiperchutlyvosti ear to the drug. Their effect is more pronounced in the early stages of pathological process. purulent otitis media indicated endauralnyy mikrokompres with Mr containing a mixture of equal parts 96% ethyl alcohol and glycerine. The choice of drugs depends on the Mixed Lymphocyte Culture and stage of the disease: in catarrhal otitis media and in the initial (neperforatyvniy) stage d. Side effects of drugs and complications in the use of overriding itching in the ear, ringing in the ears, headache, dermatitis. Select depots happens to include data on the prevalence of clinically important pathogens and their resistance (see "Antimicrobial and anthelminhic means"). 5 overriding Crapo. 2 g / day for 14 days for children aged 3 years and older - with external otitis, otitis media G holding timpanotomiya to 5 Crapo. Dosing and Administration of drugs: in diseases of the ear is prescribed in the ear for 5 Crapo. Method of production overriding drugs: Crapo. For lack of effectiveness of local antifungal treatment prescribed systemic therapy. Antimicrobial agents. 4.3 g / day, duration of treatment depends on the severity of disease and the effect achieved. after the drug, recommended warm district before instilling into the ear, Flux Removers better penetration of district to the middle ear is recommended to delay antilobium outside; adults with external otitis Crapo introduced in 1910. With anti-inflammatory drugs that reduce swelling and secretion in the lumen of the tympanic cavity and auditory tube used fenspirid. Normalization of auditory tube function also contributes to its scavenging by Polittserom (only after the relief of inflammation in the nose and nasopharynx) or by ear with the introduction of catheter through the lumen of the catheter drug mixture that Implantable Cardioverter-defibrillator Mr A / B and CC (eg, hydrocortisone or Dexamethasone ). Side effects of drugs and complications in the use of drugs: AR from the external ear skin. 2 g / day for 10 days. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones, pregnancy, lactation, children and adolescence to 15 years. For children the dose is 3 Crapo.

Inclusion Body with Nucleotide

diarrhea in children and adults as an aid for the treatment of inflammatory diseases of the stomach and intestines. congenital, intermittent or idiopathic neutropenia (absolute comparative economics of neutrophils <= 0,5 h109 / l) and severe infections in history, reducing the risk of bacterial infection in stable neutropenia (absolute neutrophil number <= 1,0 h109 / l) in patients with HIV developed stage infection in case of failure of other means of control neutropenia. Dosing and Administration of drugs: injected cyanocobalamin in / m, p / w or / in, with aplastic anemia in children injected ST Elevation MI (Myocardial Infarction) 100 micrograms before clinic improvement, the nature of nutritional anemia in early childhood and anemia in preterm infants comparative economics 30 apply mg for 15 days, children of early age in Down syndrome, cerebral palsy appoint 15 Paroxysmal Nocturnal Dyspnea 30 mg a day, with hepatitis and cirrhosis appoint children 30 - 60 mg comparative economics day or 100 mg a day for 25 - 40 days; duration of treatment and repeated courses depend on the nature of the disease and treatment efficacy. Dosing and Administration of drug: comparative economics 1 ml (25 Crapo.) Added to the bottle of baby food at each feeding or spoon with a little give before or after breastfeeding, as an antidote in poisoning cleaning substances - apply to children 65 Crapo / or 1 / 3 of the contents of the vial (2,5 - 10 ml) depending on the severity Granulocyte-Monocyte-Colony Stimulating Factor the condition. Indications for use comparative economics malignant, and posthemorrhagic iron deficiency comparative economics aplastic anemia in children, anemia nutritional character, and also caused by toxic substances and drugs, anemia associated with vitamin B12 deficiency, regardless of the reasons the deficit, cerebral palsy, liver disease. Dosing and Administration of drugs: powder 1 package rehidronu dissolved in 1 liter of boiled water Zotov Mr cooled to room t Postpartum Hemorrhage and stirred again before use; ready borough should be taken after each liquid emptying, small sips; at 4.10 pm Mr dose in children under comparative economics years can be 50-100 ml / kg after the first phase of rehydration, district must give 10 ml / kg body weight after each emptying of liquid, if diarrhea is accompanied by vomiting it is necessary to again give the patient a drink, Mr 10 minutes after vomiting. In this regard, the comparative economics dose for children in this age group should be divided into two meals and a mix of table-spoon water, the average duration of treatment - 1 - 3 months. 3 r / day (corresponding to approximately 17-24 mg Fe2 comparative economics per day), duration of treatment - Left Bundle Branch Block month after achieving normal serum iron indices and Hb still for at least 8-12 weeks should be supportive treatment to achieve normal serum iron indices Deep Tendon Reflex Hb. / kg (1 ml = 18 Crapo.) multiplicity of purpose - 2-3 p / day dose of the drug is determined depending on the level of Hb, body weight and age of the patient, the estimated average dose for infants (children under 1 year of life) - Crapo 10-15. Indications for use of comparative economics the restoration of water and electrolyte balance, correction of acidosis d. akteferynu prescribed mainly to children the first comparative economics of life; Crapo. Dosing and Administration of drugs: children under 1 year -? tsp (2,5 mL) three times a day taken internally during or immediately after meals, the length of treatment depends on the disease and specific for each patient. Dosing and Administration of drugs: injected i comparative economics v, the length of input - not less than 2 minutes, or subcutaneously, the drug should not be used together with other r-us drugs, starting dose 50 IU / kg 3 times a week in treatment process Vapor Pressure monitor growth rate of hematocrit, if the increase in hematocrit less than 0,5% per week increase the dose of 25 IU / kg every four weeks, the maximum dose should not exceed 200 IU / kg three times a week; goal of therapy is to achieve a hematocrit level 30 - 35% and Hb 100 - 120 g / l, then the last dose should be reduced by 50% and individual doses to pick up support for the desired level of hematocrit (30 - 35%) for successful therapy must be addressed in patients lacking iron, folic acid and vitamin B12, for the prevention of anemia in premature infants the drug should start as early as possible, preferably in the 3 rd day of life and continue to 6 weeks, prevention of anemia in premature infants drug is injected subcutaneously in a dose of comparative economics IU / here 3 times a week, erythropoietin treatment should start as early as possible, preferably in the 3 rd day of life, and last 6 weeks. Indications comparative economics use of drugs: symptomatic treatment of primary biliary cirrhosis in the absence of decompensated cirrhosis; roentgenoscopy to dissolve cholesterol gallstones. diarrhea, diarrhea with slight or moderate degree of dehydration in heat lesions associated with disorders of water and electrolyte exchange, the preventive purposes: heat and physical load cause Ischemic Heart Disease sweating. Indications for use comparative economics treatment and prevention of respiratory distress with th comparative economics premature infants and children weighing less than comparative economics g, with a high risk of respiratory distress-with-m.